Mitra Biotech is an Indian-American venture founded in 2009. Mallik Sundaram co-founded Mitra Biotech. He serves as the President and CEO of Mitra Biotech since its inception. The aim of Mitra Biotech has been to become a partner of choice to global pharmaceutical and biotech companies. They wanted to support new drug development as they navigate from late discovery to preclinical and clinical stages.
Their objective is to enable rational drug discovery and personalized cancer care. Their preclinical platform CANScript™ facilitates customized cancer care by selection of optimal drug combination for the patient under treatment. Mitra Biotech also has a tumor bank, which houses over 600 viable tumors in early passage. They further …show more content…
Being a new method of treating Cancer replacing the usual chemotherapy treatment, it is very essential to ensure the pharma companies in effectiveness of the drug, delivering the quality service to its customers.
Care: Enhancing the quality of life of the Cancer patients by providing them pain-free treatment and providing doctors the effective means of curing patients’ illness.
Integrity: To be consistent in delivering value to its customers in the right way. Being the new innovative way of treating the dreadful disease; there lies high uncertainty in accepting the method against the usual chemotherapy. Hence, in order to make the world available with effective treatment method, Mitra Biotech ought to deliver the best value to its …show more content…
Also it helps the company to get the sophisticated skilled people it is looking for.
Global investors
As the number of VC and PE funds that focus on biotechnology space are less in number, the company is focusing on global investors to get the fusing required for early stage research and market development. These investments from global investors will also help company enter in to new markets like U.S, Europe and other global nations. Mitra Biotech currently funded by Accel partners,
Cancer hospitals
As the technology is new, doctors and patients are sceptical of its use. To overcome this challenge, Mitra Biotech has entered in to partnerships and tie ups with different hospitals. In Asia, the company has currently tie ups with Health care Global enterprise Ltd (South Asia’s largest cancer care network) and Tata memorial hospital (Focused on cancer treatment). Also it is involved in CSR activities to bring the awareness among the people on cancer and its drug usage. Wrong drug usage for a wrong cancer is of no help to patient and also increases the toxic levels inside the patient